Black patients with schizophrenia had a lower likelihood of receiving a clozapine prescription compared with White patients, even after analyses accounted for demographic variables, social determinants of health, and care access patterns. Given the effectiveness of clozapine in managing treatment-resistant schizophrenia, it is crucial for future research to better understand the factors contributing to this treatment disparity.
Keyphrases
- healthcare
- end stage renal disease
- newly diagnosed
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- bipolar disorder
- public health
- palliative care
- systematic review
- mental health
- prognostic factors
- quality improvement
- current status
- risk assessment
- african american
- human health
- health insurance
- smoking cessation